Nautilus Biotechnology(NAUT) - 2024 Q4 - Earnings Call Presentation

Delivering on the Promise of the Proteome FEBRUARY 27, 2025 Safe harbor This presentation and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the size and growth of the protein analysis market; Nautilus Biotechnology's anticipated total addressable market; the performance, value and enabling nature of Nautilus Biotechnology's proteomics and proteoform analysis techn ...